Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation.
Antoniu
Sabina A
SA
Clinic of Pulmonary Disease, University of Medicine and Pharmacy Gr.T.Popa, Iasi, Romania. sabinaantoniu@excite.com
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D006801:Humans; D011653:Pulmonary Diffusing Capacity / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D011728:Pyridones / Q000009:adverse effects / Q000627:therapeutic use*; D011788:Quality of Life; D014109:Total Lung Capacity / Q000187:drug effects; D014797:Vital Capacity / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011728:Pyridones; C093844:pirfenidone